Findings on Ovarian Cancer Detailed by Investigators at Duke University (The Efficacy and Safety of Mirvetuximab Soravtansine In Fra-positive, Third- Line and Later, Recurrent Platinum-sensitive Ovarian Cancer: the Single-arm Phase Ii Piccolo ...)

Media coverage

• Title	Findings on Ovarian Cancer Detailed by Investigators at Duke University (The Efficacy and Safety of Mirvetuximab Soravtansine In Fra-positive, Third- Line and Later, Recurrent Platinum-sensitive Ovarian Cancer: the Single-arm Phase Ii Piccolo ...)
  Media name/outlet	NewsRx Women's Health Daily
  Country/Territory	United States
  Date	03/26/25
  Persons	Y. Lynn Wang